Literature DB >> 11877649

Staged reconstruction of large congenital diaphragmatic defects with synthetic patch followed by reverse latissimus dorsi muscle.

Steven L Lee1, Nicholas D Poulos, Stephen K Greenholz.   

Abstract

BACKGROUND/
PURPOSE: Synthetic repair of large congenital diaphragmatic defects (>90%) invariably will lead to recurrence, progressive chest wall deformity, and restrictive pulmonary disease. Staged reconstruction with living, growing tissue can help avoid these complications.
METHODS: Between November 1995 and December 1999, 5 patients (median age, 25 months) with diaphragmatic agenesis underwent staged replacement with a reverse latissimus dorsi (RLD) flap. All required extracorporeal membrane oxygenation (ECMO) support at birth followed by synthetic patch (polytetrafluoroethylene or PTFE) diaphragm closure. Clinical evidence of patch disproportion, including recurrence (n = 3), chest wall deformity (n = 3), radiographic findings (n = 2), and restrictive respiratory patterns (n = 1), provided indication for replacement. The procedure involves removal of the original patch via thoracotomy followed by transposition of a RLD flap (based on the paraspinous and intercostal perforating vessels) into the defect through the bed of the 10th rib. Two patients underwent concomitant fundoplication.
RESULTS: RLD flap was completed successfully in all 5 patients. Median length of stay after the procedure was 8 days. With a mean follow-up of 28 months (15 to 64 months), there have been no recurrences and no complications related to the procedure. Respiratory status and chest wall deformity have improved. There was neither evidence of paradoxical chest wall movement nor obvious limitation of the ipsilateral upper extremity on physical examination. The RLD flaps have grown proportionately to the children and remained at a stable level on chest x-ray.
CONCLUSIONS: Staged reconstruction with patch closure followed by definitive reverse latissimus dorsi flap repair is a safe and highly effective treatment option in patients with diaphragmatic agenesis. A planned replacement should be considered in all patients with severe diaphragmatic hernias and patch closure before the development of thoracic complications. Copyright 2002 by W.B. Saunders Company.

Entities:  

Mesh:

Year:  2002        PMID: 11877649     DOI: 10.1053/jpsu.2002.30837

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  6 in total

1.  Toldt's fascia flap: a new technique for repairing large diaphragmatic hernias.

Authors:  Tadaharu Okazaki; Shiro Hasegawa; Naoto Urushihara; Koji Fukumoto; Kaoru Ogura; Shintaro Minato; Shoko Kawashima; Sumio Kohno
Journal:  Pediatr Surg Int       Date:  2005-01       Impact factor: 1.827

2.  Abdominal muscle flap repair for large defects of the diaphragm.

Authors:  S B Joshi; Sudipta Sen; Jacob Chacko; Gordon Thomas; Sampath Karl
Journal:  Pediatr Surg Int       Date:  2005-07-12       Impact factor: 1.827

3.  Morphometric properties of the latissimus dorsi muscle in human fetuses for flap surgery.

Authors:  Orhan Beger; Burhan Beger; Deniz Uzmansel; Semra Erdoğan; Zeliha Kurtoğlu
Journal:  Surg Radiol Anat       Date:  2017-11-16       Impact factor: 1.246

4.  Generation of a Functioning and Self-Renewing Diaphragmatic Muscle Construct.

Authors:  Caterina Trevisan; Mario Enrique Alvrez Fallas; Edoardo Maghin; Chiara Franzin; Piero Pavan; Paola Caccin; Angela Chiavegato; Eugenia Carraro; Daniele Boso; Francesco Boldrin; Federico Caicci; Enrica Bertin; Luca Urbani; Anna Milan; Carlo Biz; Lorenza Lazzari; Paolo De Coppi; Michela Pozzobon; Martina Piccoli
Journal:  Stem Cells Transl Med       Date:  2019-04-10       Impact factor: 6.940

5.  Anterior fundoplication at the time of congenital diaphragmatic hernia repair.

Authors:  Yigit S Guner; Steven Elliott; Clifford C Marr; Stephen K Greenholz
Journal:  Pediatr Surg Int       Date:  2009-07-04       Impact factor: 1.827

6.  Thoracic wall reconstruction with Collamend® in trauma: report of a case and review of the literature.

Authors:  Federico Coccolini; Marco Lotti; Paolo Bertoli; Roberto Manfredi; Dario Piazzalunga; Stefano Magnone; Luca Campanati; Luca Ansaloni
Journal:  World J Emerg Surg       Date:  2012-12-23       Impact factor: 5.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.